Zhejiang Hisun Pharmaceutical's (SHA:600267) subsidiary, Zhejiang Hisun Animal Health Products, received veterinary drug approval certificates from China's Ministry of Agriculture and Rural Affairs for its Compound Fipronil, Praziquantel and Moxidectin Topical Solution, according to Shanghai bourse filing on Tuesday.
THe drug is used to prevent and treat internal and external parasitic infections in cats, including flea and tick infections.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments